| human | Q5 |
| P6178 | Dimensions author ID | 014174653757.88 |
| P227 | GND ID | 12919459X |
| P213 | ISNI | 0000000116385388 |
| P244 | Library of Congress authority ID | n2002134913 |
| P1207 | NUKAT ID | n2003072413 |
| P496 | ORCID iD | 0000-0003-4712-8979 |
| P7293 | PLWABN ID | 9810537573505606 |
| P214 | VIAF ID | 49448853 |
| P10832 | WorldCat Entities ID | E39PBJyMkrJJX8hGfcRD3hDDv3 |
| P108 | employer | Klinikum am Weissenhof | Q1774661 |
| P734 | family name | Grunze | Q111759333 |
| Grunze | Q111759333 | ||
| Grunze | Q111759333 | ||
| P735 | given name | Heinz | Q11682369 |
| Heinz | Q11682369 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q46428905 | A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode |
| Q57612732 | A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant Rapid-Cycling Bipolar Disorder |
| Q60646355 | A European perspective on the Canadian guidelines for bipolar disorder |
| Q48077458 | A bipolar II cohort (ABC): The association of functional disability with gender and rapid cycling |
| Q60646382 | A calcium antagonist for the treatment of depressive episodes: Single case reports |
| Q46904273 | A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities |
| Q34658735 | A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression |
| Q42625302 | A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. |
| Q45237779 | A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder |
| Q30884720 | A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. |
| Q60646371 | Acetazolamide in the Treatment of Acute Mania |
| Q44272770 | Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design |
| Q50586394 | Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis. |
| Q44286530 | Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups |
| Q45936573 | Age at Onset of Bipolar Disorder Related to Parental and Grandparental Illness Burden. |
| Q39620917 | Age of onset of bipolar disorder: Combined effect of childhood adversity and familial loading of psychiatric disorders |
| Q60646345 | Akut- und Langzeittherapie der bipolaren Depressionen |
| Q46749979 | Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism |
| Q34643710 | Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism |
| Q57612772 | An Exploratory Open Trial on Safety and Efficacy of the Anticonvulsant Retigabine in Acute Manic Patients |
| Q53943806 | An open label study of gabapentin in the treatment of acute mania. |
| Q42645137 | An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization |
| Q30482552 | An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). |
| Q35236134 | Anticonvulsant drugs in bipolar disorder. |
| Q60646346 | Anticonvulsants in bipolar disorder |
| Q42081136 | Anticonvulsants in the treatment of aggression in the demented elderly: an update |
| Q47924379 | Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. |
| Q37039104 | Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. |
| Q36827444 | Antiepileptic drugs and mood stability. |
| Q36169536 | Antiepileptic drugs in mood-disordered patients |
| Q42655106 | Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design |
| Q52937654 | Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression? |
| Q37104894 | Are bipolar mood symptoms affected by the phase of the menstrual cycle? |
| Q37947705 | Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance |
| Q38749001 | Assessment and management of agitation in psychiatry: Expert consensus |
| Q34452500 | Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I. |
| Q51905399 | Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. |
| Q38648206 | At the edge of the bipolar spectrum: primacy of affective over psychotic symptoms or vice versa? |
| Q36204462 | Atypical antipsychotics in bipolar depression: potential mechanisms of action. |
| Q45065024 | Bipolar disorders--how to recognize and treat them |
| Q48397213 | Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies |
| Q48381221 | Calcium-antagonistic effects of carbamazepine in epilepsies and affective psychoses |
| Q30666996 | Central pontine myelinolysis in a patient with anorexia nervosa |
| Q46189290 | Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder |
| Q38211511 | Clinical decision making in the treatment of mixed states |
| Q34563533 | Clinical relevance and treatment possibilities of bipolar rapid cycling. |
| Q43917649 | Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series |
| Q33179619 | Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects |
| Q51866133 | Cognitive functioning in euthymic bipolar I and bipolar II patients. |
| Q60646380 | Combined treatment with lithium and nimodipine in a bipolar I manic syndrome |
| Q34833550 | Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study |
| Q95463273 | Comparative efficacy of anti-manic drugs in acute mania |
| Q51928394 | Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. |
| Q42869342 | Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder |
| Q60646341 | Coping style and bipolarity |
| Q60646356 | Correlates of overweight and obesity in 644 patients with bipolar disorder |
| Q46037763 | Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. |
| Q60646343 | Deeskalationstechniken und atypische Neuroleptika in der Behandlung der akuten Manie |
| Q47578570 | Developing core sets for persons with bipolar disorder based on the International Classification of Functioning, Disability and Health |
| Q60646372 | Differential Treatment of Bipolar Disorder with Old and New Antiepileptic Drugs |
| Q39802523 | Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany |
| Q45797033 | Differential diagnosis of and pharmacotherapy for bipolar disorder |
| Q30997997 | Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review |
| Q51915417 | Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. |
| Q38774132 | Dysregulation of ion fluxes in bipolar affective disorder. |
| Q39672440 | EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects |
| Q43406851 | Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood |
| Q34429829 | Effects of kawain and dihydromethysticin on field potential changes in the hippocampus. |
| Q46631348 | Effects of lamotrigine on field potentials and long-term potentiation in guinea pig hippocampal slices |
| Q42597523 | Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate |
| Q60646366 | Elektrokonvulsionstherapie in der Behandlung der schweren Manie |
| Q46974057 | Ergenyl chronospheres in bipolar disorders |
| Q34676317 | Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology |
| Q47377938 | Facial emotion labeling in unaffected offspring of adults with bipolar I disorder |
| Q43776575 | Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network |
| Q47844776 | Family environment of bipolar families: a UK study |
| Q60646373 | Female Genital Disorder as Adverse Symptom of Lamotrigine Treatment |
| Q38845154 | Further Evidence of a Cohort Effect in Bipolar Disorder: More Early Onsets and Family History of Psychiatric Illness in More Recent Epochs |
| Q48861418 | Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network |
| Q44427295 | Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder |
| Q33942947 | Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? |
| Q35219846 | Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States |
| Q38980741 | Illnesses in siblings of US patients with bipolar disorder relate to multigenerational family history and patients severity of illness |
| Q46055220 | Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study |
| Q28182929 | Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up |
| Q50949917 | Impact of cognitive-psychoeducational interventions in bipolar patients and their relatives. |
| Q50990875 | Impaired functioning in euthymic patients with bipolar disorder--HSV-1 as a predictor. |
| Q60646349 | Incidence of childhood-onset bipolar illness in the USA and Europe |
| Q40540600 | Incidence, characteristics and course of narrow phenotype paediatric bipolar I disorder in the British Isles |
| Q44962068 | Increased parental history of bipolar disorder in the United States: association with early age of onset |
| Q40766277 | Increases in multiple psychiatric disorders in parents and grandparents of patients with bipolar disorder from the USA compared with The Netherlands and Germany |
| Q40678347 | Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. |
| Q34324648 | Influence of biperiden and bornaprine on sleep in healthy subjects |
| Q60646352 | Influence of sub-syndromal symptoms after remission from manic or mixed episodes |
| Q34790180 | Interferon alpha (IFNalpha) and psychiatric syndromes: a review |
| Q43834635 | Interferon alpha-associated agranulocytosis during clozapine treatment. Case report and status of current knowledge |
| Q34208183 | Interpreting magnetic resonance imaging findings in bipolar disorder. |
| Q60646364 | Intravenous Valproate Loading in Acutely Manic and Depressed Bipolar I Patients |
| Q43290179 | Invited comment |
| Q36256635 | Is the prophylactic antidepressant efficacy of lithium in bipolar I disorder dependent on study design and lithium level? |
| Q60646359 | Klinische Relevanz und Behandlungsmöglichkeiten von Rapid Cycling bei Patienten mit bipolarer affektiver Störung |
| Q59791616 | Klinischer Stellenwert der Valproat-Therapie bei bipolaren Störungen |
| Q43986321 | Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study |
| Q46385209 | Lamotrigine in bipolar disorder: results of a mirror-image evaluation using the NIMH Lifechart-Methodology |
| Q34475914 | Lamotrigine in the treatment of schizoaffective disorder |
| Q48447285 | Lamotrigine may limit pathological excitation in the hippocampus by modulating a transient potassium outward current |
| Q60646353 | Leitlinien zur Therapie der akuten Manie |
| Q44559995 | Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design |
| Q60646358 | Life charts on a palmtop computer: first results of a feasibility study with an electronic diary for bipolar patients |
| Q35194827 | Lithium in the acute treatment of bipolar disorders-a stocktaking |
| Q46055681 | Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants |
| Q112575814 | Mania and bipolar depression: complementing not opposing poles-a post-hoc analysis of mixed features in manic and hypomanic episodes |
| Q46154953 | Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders |
| Q40800094 | Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network |
| Q60646354 | Mixed Hypomania in 908 Patients With Bipolar Disorder Evaluated Prospectively in the Stanley Foundation Bipolar Treatment Network |
| Q46453718 | Modulation of calcium and potassium currents by lamotrigine |
| Q46158717 | Modulation of neural cell membrane conductance by the herbal anxiolytic and antiepileptic drug aswal |
| Q50929769 | Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. |
| Q26776522 | More illness in offspring of bipolar patients from the U.S. compared to Europe |
| Q47603494 | More medical comorbidities in patients with bipolar disorder from the United States than from the Netherlands and Germany |
| Q44004420 | More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment |
| Q44633950 | More stressors prior to and during the course of bipolar illness in patients from the United States compared with the Netherlands and Germany |
| Q46948351 | Multigenerational Positive Family History of Psychiatric Disorders Is Associated With a Poor Prognosis in Bipolar Disorder |
| Q56535598 | Multigenerational transmission of liability to psychiatric illness in offspring of parents with bipolar disorder |
| Q28326548 | Myoclonic epileptic seizures during clozapine treatment: a report of three cases |
| Q49058538 | NMDA-dependent modulation of CA1 local circuit inhibition. |
| Q42694300 | Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol |
| Q40416216 | Neurochemical underpinnings in bipolar disorder and epilepsy |
| Q43661153 | Neuroimaging of bipolar disorders |
| Q39180645 | Neuropsychological study of IQ scores in offspring of parents with bipolar I disorder |
| Q35236252 | Neurotoxicity of NMDA antagonists: a glutamatergic theory of schizophrenia based on selective impairment of local inhibitory feedback circuits. |
| Q60646362 | New Insights into the Mechanisms and Sites of Action of Lamotrigine |
| Q36680747 | New findings from the Bipolar Collaborative Network: clinical implications for therapeutics |
| Q35073842 | New perspectives in the acute treatment of bipolar depression. |
| Q39444069 | New perspectives in the treatment of acute mania: a single case report |
| Q46601299 | Newer prophylactic agents for bipolar disorder and their influence on suicidality |
| Q32061374 | Non-fatal effect of highly toxic amitriptyline level after suicide attempt. A case report |
| Q44744247 | Olanzapine (Zyprexa)--reliable in acute treatment, prevention of recurrence and long-term mood stabilization |
| Q28259736 | Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial |
| Q43977912 | Onset of depressive episodes is faster in patients with bipolar versus unipolar depressive disorder: evidence from a retrospective comparative study |
| Q43942064 | Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. |
| Q44893004 | Paroxetine in major depression: correlating plasma concentrations and clinical response |
| Q48368506 | Phenomenology of manic episodes according to the presence or absence of depressive features as defined in DSM-5: Results from the IMPACT self-reported online survey |
| Q38098607 | Physical health of patients with bipolar disorder |
| Q38143335 | Polypharmacy and bipolar disorder: what's personality got to do with it? |
| Q42650683 | Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder |
| Q57612656 | Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology |
| Q47646557 | Prevalence of axis II comorbidities in bipolar disorder: relationship to mood state. |
| Q46971602 | Prophylaxis of bipolar disorder |
| Q51413350 | Psychopathological and auditory evoked potential correlates of ketamine psychosis--a single case report. |
| Q45288751 | Psychopathological changes preceding motor symptoms in Huntington's disease: a report on four cases |
| Q60646357 | Psychopharmakotherapie bipolarer affektiver Erkrankungen |
| Q46558537 | Puzzling bipolar disorder |
| Q42633550 | Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network |
| Q42947666 | Quetiapine is effective in the treatment of adults in the acute phase of bipolar depression |
| Q95400660 | Randomised controlled trial of Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression (ADD Study) |
| Q46181756 | Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs. |
| Q36204441 | Reevaluating therapies for bipolar depression. |
| Q47582050 | Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder |
| Q48703471 | Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients |
| Q34531406 | Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder |
| Q60646377 | Renal Impairment as a Possible Side Effect of Gabapentin |
| Q46494852 | Reproductive function and risk for PCOS in women treated for bipolar disorder |
| Q53058789 | Response to Shen J, Kobak K, Zhao Y, et al. Use of remote centralized raters via live 2-way video ina multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693). |
| Q46921505 | Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers |
| Q42631462 | Risperidone monotherapy in manic inpatients: an open label, multicentre trial |
| Q44964084 | Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder |
| Q38584632 | Safety and tolerability of anticonvulsant medication in bipolar disorder |
| Q33650472 | Saving time and money: a validation of the self ratings on the prospective NIMH Life-Chart Method (NIMH-LCM) |
| Q34660649 | Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cells |
| Q45095387 | Serum levels of substance P and response to antidepressant pharmacotherapy |
| Q60646360 | Short-term and Long-term Effects of N-Methyl-D-Aspartate Receptor Hypofunction |
| Q60646347 | Spezifische Behandlungsaspekte bipolar erkrankter Frauen |
| Q38265910 | Stimulants for treating bipolar disorder: pro and con. |
| Q51910102 | Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. |
| Q93186451 | Testing a clinical staging model for bipolar disorder using longitudinal life chart data |
| Q28066714 | The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm |
| Q28076486 | The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines |
| Q28072601 | The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future Research |
| Q37558582 | The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders |
| Q30583384 | The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders |
| Q44305104 | The Stanley Foundation Bipolar Network: results of the naturalistic follow-up study after 2.5 years of follow-up in the German centres |
| Q34616633 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression |
| Q34550618 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment |
| Q34606256 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania |
| Q34649187 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder |
| Q43446484 | The challenge of treating bipolar outpatients |
| Q37872252 | The clinical side of bipolar disorders |
| Q35142948 | The clinical use of gabapentin in bipolar spectrum disorders |
| Q37610170 | The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action |
| Q46655029 | The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study. |
| Q44620166 | The poor prognosis of childhood-onset bipolar disorder |
| Q82582553 | The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice |
| Q46094752 | The relevance of dopamine agonists in the treatment of depression |
| Q36235502 | The safety and tolerability of atypical antipsychotics in bipolar disorder |
| Q42412787 | The use of atypical antipsychotics in Bipolar Spectrum disorders |
| Q34511929 | The use of tiagabine in affective disorders. |
| Q51900824 | Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. |
| Q39434446 | Tiagabine appears not to be efficacious in the treatment of acute mania |
| Q46877866 | Tourette's symptoms provoked by lamotrigine in a bipolar patient |
| Q60646350 | Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study |
| Q44632678 | Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression |
| Q60646363 | Treatment of acute mania with topiramate |
| Q37013938 | Treatment of bipolar depression: an update |
| Q60646340 | Treatment of bipolar disorder: not another meta-analysis |
| Q60646367 | Treatment of tardive akathisia with clonidine: a case report |
| Q38003198 | Treatment options for acute depression in bipolar disorder |
| Q50747884 | Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers. |
| Q48093386 | Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy. |
| Q44859516 | Use of quetiapine in bipolar disorder: a case series with prospective evaluation |
| Q44039028 | Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of bipolar disorder |
| Q34554377 | What works for delirious catatonic mania? |
| Q27014860 | When to start aripiprazole therapy in patients with bipolar mania |
| Q60646361 | Wirksamkeit, Verträglichkeit und Praktikabilität von Valproat-Miniretardtabletten bei bipolaren affektiven Störungen |
| Q35024109 | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression |
| Q44199259 | Ziprasidone--not haloperidol--induces more de-novo neurogenesis of adult neural stem cells derived from murine hippocampus |
| Q28273414 | Zotepine loading in acute and severely manic patients: a pilot study |
| Q50740011 | [Annual costs of bipolar disorders in Germany]. |
| Q60646351 | [Anticonvulsants in the treatment of bipolar disorder] |
| Q84842791 | [Are atypical antipsychotic drugs the first line treatment for bipolar disorders? For] |
| Q60646348 | [Bipolar disorders] |
| Q50743258 | [Cognitive-psychoeducational group programme for bipolar disorder: pilot study with two-year follow-up]. |
| Q53929025 | [Gabapentin in the treatment of mania]. |
| Q60646383 | [Generalized epileptic seizures in treatment with clozapine. Incidence, types, prognosis and recommendations with reference to therapeutic strategies] |
| Q60646365 | [M Adli, T.Bschor, B. Canata. S. Döpfmer, M. Bauer: Lithium in the treatment of acute depression. Fortschr Neurol Psychiat 199866: 43] |
| Q60646368 | [Predictors of response to phase prophylactics (mood stabilizers) in bipolar affective disorders] |
| Q52095056 | [Problem-based learning in medical education. Integrated "Nervous System and Behavior" course at the Munich Ludwig Maximilian University]. |
| Q53083112 | [Reliability and concordance validity of a German version of the Young Mania Rating Scale (YMRS-D)]. |
| Q58444043 | [Speed of onset of depressive episodes: a clinical criterion helpful for separating uni- from bipolar affective disorders] |
| Q50771300 | [Suicidality and the Internet. Danger from new media]. |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.